These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [New observation on the effects of vagal infiltration in gastric ulcer, with emphasis on the gastric secretion]. MUGLER A, KURTZEMANN G. Strasb Med; 1951 Dec; 2(12):811-5. PubMed ID: 14922087 [No Abstract] [Full Text] [Related]
29. [CLINICAL SIGNIFICANCE OF THE DETERMINATION OF UROPEPSINOGEN IN PEPTIC ULCER]. LUZHIS AR, RYSS IeS. Vestn Akad Med Nauk SSSR; 1963 Dec; 18():60-5. PubMed ID: 14133795 [No Abstract] [Full Text] [Related]
30. In vitro neutralizing capacity of commercially available antacid mixtures, and their role in the treatment of peptic ulcer. Clain JE, Wright JP, Price RN, Marks IN. S Afr Med J; 1980 Feb 02; 57(5):158-60. PubMed ID: 7404127 [Abstract] [Full Text] [Related]
31. Assessment of gastric acidity and pepsin in relation to peptic ulcer. I. Acidity of the gastric contents. PORELL WJ, HOWE CW. BMQ; 1951 Sep 02; 2(3):73-77. PubMed ID: 14878692 [No Abstract] [Full Text] [Related]
32. Evaluation of a new atropine-brand anticholinergic; clinical, gastric secretory and roentgenological effects in peptic ulcer and gastrointestinal functional disorders. ROSSIEN AX. Am J Gastroenterol; 1956 Aug 02; 26(2):170-98. PubMed ID: 13339770 [No Abstract] [Full Text] [Related]
39. [Treatment of peptic ulcer of the stomach and the duodenum with special reference to ganglion blocking agents and a new ulcer drug]. FAULHAMMER O. Med Klin; 1955 Dec 30; 50(52):2201-2. PubMed ID: 13296771 [No Abstract] [Full Text] [Related]
40. DAA: its antacid effect and use in peptic ulcer. RIDER JA, GIBBS JO, SWADER J, VAN DER REIS L, LEE J. Am J Dig Dis; 1956 Jul 30; 1(7):287-93. PubMed ID: 13339751 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]